Pipeline Preview for January 1, 2002
Get the latest industry news, event updates, and more from Managed healthcare Executive.
Repatha Now Available for Approximately 60% Off List Price
Read More
Novartis to Offer Cosentyx to Cash Paying Patients at a 55% Discount
Amneal Submits BLA for Potential Xolair Biosimilar
Novo Nordisk Resubmits BLA for Once-Weekly Insulin for Type 2 Diabetes
FDA Approves Extended Indication for Evkeeza
AstraZeneca to Offer Airsupra Direct to Patient